Skip to main content
See every side of every news story
Published loading...Updated

Edwards Lifesciences Reports New Clinical Trial Updates - Orange County Business Journal

Summary by ocbj.com
Irvine-based Edwards Lifesciences Corp. today announced newly presented data from several of its clinical trials. The data, presented at the annual New York Valves 2026 conference, included seven-year benchmark results from its Partner 3 trial, as well as new findings from its Early TAVR trial. Both trials are using Edwards’ Sapien 3 transcatheter heart valve and “strengthen the evidence base” for the platform, according to the company. “Our exp…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

ocbj.com broke the news on Friday, June 26, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal